Learn More
Medchemexpress LLC Methyl protodioscin | 54522-52-0 | 1063.23 | 1 ML

Supplier: Medchemexpress LLC HYN086310MM/1ML
Methyl protodioscin is a multi-target, selective, steroidal diglycoside inhibitor with antitumor activity that induces cell cycle arrest. It exhibits significant antitumor, anti-inflammatory, and anti-restenosis activities, making it suitable for research on various cancers and inflammatory diseases.
- Induces G2/M cell cycle arrest.
- Regulates Bcl-2/Bax apoptotic pathway.
- Inhibits Akt1/c-Myc axis and MAPK/ERK signaling.
- Reduces cholesterol synthesis by downregulating ADAM15 and inducing FOXO1.
- Inhibits JNK/c-Jun pathway to reduce inflammatory factors.
- Shows potent antitumor effects, including inhibiting proliferation, migration, and invasion.
- Demonstrates anti-inflammatory and anti-restenosis properties.
- Useful in lung, prostate, and pancreatic cancer research.
- Applicable in studies of airway inflammation and enteritis.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.